Loading...
*  Fibrinolysis
... primary fibrinolysis and secondary fibrinolysis. The primary type is a normal body process, whereas secondary fibrinolysis is ... Testing of overall fibrinolysis can be measured by a euglobulin lysis time (ELT) assay. The ELT measures fibrinolysis by ... In this assay, increased fibrinolysis is assessed by comparing the TEM profile in the absence or presence of the fibrinolysis ... In fibrinolysis, a fibrin clot, the product of coagulation, is broken down. Its main enzyme plasmin cuts the fibrin mesh at ...
*  Thrombomodulin
... -bound thrombin has procoagulant effect at the same time by inhibiting fibrinolysis by cleaving thrombin- ... activatable fibrinolysis inhibitor (TAFI, aka carboxypeptidase B2) into its active form.[citation needed] Thrombomodulin is a ...
*  Urokinase
... it causes significant fibrinogenolysis and clot fibrinolysis making its use less favorable than TPA. GRCh38: Ensembl release 89 ...
*  Plasminogen activator inhibitor-1
Thus, PAI can be said to inhibit the serine proteases tPA and uPA/urokinase, and hence is an inhibitor of fibrinolysis, the ... Congenital deficiency of PAI-1 has been reported; as fibrinolysis is not suppressed adequately, it leads to a hemorrhagic ... Wang J, Li J, Liu Q (August 2005). "Association between platelet activation and fibrinolysis in acute stroke patients". ... lower PAI levels would lead to less suppression of fibrinolysis and conversely a more rapid degradation of the fibrin. ...
*  Fibrinolysis syndrome
... (also known as "Defibrinating syndrome") is characterized by an acute hemorrhagic state brought about by ... The cause for Fibrinolysis syndrome, is the inability of the body to produce blood-coagulates to stop bleeding. What causes the ...
*  Thrombin-activatable fibrinolysis inhibitor
Term thrombin-activatable fibrinolysis inhibitor may refer to: Carboxypeptidase B2, an enzyme that in humans is encoded by the ...
*  Tissue factor pathway inhibitor
Fibrinolysis. 5 (4): 551-9. PMID 7841311. ...
*  Dilute Russell's viper venom time
Fibrinolysis. 15 (3): 279-82. doi:10.1097/00001721-200404000-00015. PMID 15060428. [non-primary source needed] Miyakis, S; ...
*  Reviparin sodium
Fibrinolysis. 4 Suppl 1: S55-8; discussion S59-60. PMID 8180331. Karsch KR, Preisack MB, Baildon R, Eschenfelder V, Foley D, ...
*  VLDL receptor
Fibrinolysis. 19 (6): 543-55. doi:10.1097/MBC.0b013e3283068859. PMID 18685438. Llorca J, Rodríguez-Rodríguez E, Dierssen-Sotos ... Fibrinolysis. 19 (2): 166-77. doi:10.1097/MBC.0b013e3282f5457b. PMID 18277139. Ananyeva NM, Makogonenko YM, Sarafanov AG, ...
*  HABP2
Fibrinolysis. 13 (5): 433-41. doi:10.1097/00001721-200207000-00008. PMID 12138371. Wang KK, Liu N, Radulovich N, et al. (2002 ...
*  Platelet
Fibrinolysis. 24 (5): 484-88. doi:10.1097/MBC.0b013e32835e4230. PMID 23348429. Kornerup KN; Page CP (2007). "The role of ...
*  Ancrod
Impaired fibrinolysis. Severe liver disease. Manifest or impending shock. I.M.-Injection : Ancrod should not be injected i.m., ... acts as cofactor for the tPA-induced plasminogen activation and an increased fibrinolysis results in return (profibrinolytic ...
*  FCGR3A
Fibrinolysis. 23 (1): 45-50. doi:10.1097/mbc.0b013e32834d7ce3. PMID 22024796. Keane C, Nourse JP, Crooks P, Nguyen-Van D, ...
*  Winged infusion set
Blood Coagul Fibrinolysis. 17 (7): 557-61. doi:10.1097/01.mbc.0000245300.10387.ca. PMID 16988551. Sharp MK, Mohammad SF (Sep ...
*  Acenocoumarol
Blood Coagul Fibrinolysis. 15 (8): 673-6. doi:10.1097/00001721-200412000-00007. PMID 15613922. Lengyel M; SPORTIF-III ...
*  Gilbert's syndrome
Blood Coagul Fibrinolysis. 2013 Jul;24(5):484-8. doi: 10.1097/MBC.0b013e32835e4230. The effects of Gilbert's syndrome on the ...
*  Kadmon Corporation
Fibrinolysis. 19 (7): 709-18. doi:10.1097/MBC.0b013e32830b2891. PMC 2713681 . PMID 18832915. Lee, J; Zheng, Y; -von Bornstadt, ...
*  Brodifacoum
"I smell a rat". Blood Coagulation & Fibrinolysis. doi:10.1097/mbc.0b013e328358e959. La Rosa F; Clarke S; Lefkowitz J. B. (1997 ...
*  Factor IX
Fibrinolysis. 14 Suppl 1: S59-64. doi:10.1097/00001721-200306001-00014. PMID 14567539. Du X (May 2007). "Signaling and ...
*  Disseminated intravascular coagulation
... or fibrinolysis.[citation needed] In DIC, the processes of coagulation and fibrinolysis are dysregulated, and the result is ... resulting in fibrinolysis. The breakdown of clots results in an excess of FDPs, which have powerful anticoagulant properties, ... Blood Coagul Fibrinolysis. 18 (7): 589-93. doi:10.1097/MBC.0b013e32822d2a3c. PMID 17890943. Becker, Joseph U and Charles R Wira ... which prevents fibrinolysis. Excess circulating thrombin results from the excess activation of the coagulation cascade. The ...
*  Protein C inhibitor
Suzuki K (1 March 2000). "Protein C inhibitor (PAI-3): structure and multi-function". Fibrinolysis and Proteolysis. 14 (2): 133 ... Fibrinolysis. 4 (1): 153-8. doi:10.1097/00001721-199304010-00027. PMID 8384496. Moore A, Penfold LM, Johnson JL, Latchman DS, ... Fibrinolysis. 6 (5): 382-7. doi:10.1097/00001721-199507000-00003. PMID 8589203. The MEROPS online database for peptidases and ... Fibrinolysis. 4 (6): 921-6. doi:10.1097/00001721-199304060-00009. PMID 8148485. Hayashi T, Suzuki K (October 1993). "Gene ...
*  Staphylokinase
Vanderschueren S, Van de Werf F, Collen D (August 1997). "Recombinant staphylokinase for thrombolytic therapy". Fibrinolysis ...
*  Thrombodynamics test
2012). "Predicting prothrombotic tendencies in sepsis using spatial clot growth dynamics". Blood Coagul Fibrinolysis. 23: 498- ... Blood Coagul Fibrinolysis. 19: 743-755. doi:10.1097/MBC.0b013e3283104093. PMID 19002040. Ovanesov M.V.; Krasotkina J.V.; ...
*  Craterellus lutescens
Blood Coagulation and Fibrinolysis. 12 (2): 123-8. doi:10.1097/00001721-200103000-00006. PMID 11302474. Craterellus lutescens ...